Cintas (CTAS) EBITDA Margin (2016 - 2026)
Quarterly results put EBITDA Margin at 23.22% for Q1 2026, down 15.0% from a year ago — trailing twelve months through Feb 2026 was 22.95% (up 18.0% YoY), and the annual figure for FY2025 was 22.82%, up 127.0%.
Cintas has reported EBITDA Margin over the past 18 years, most recently at 23.22% for Q1 2026.
- EBITDA Margin reached 23.22% in Q1 2026 per CTAS's latest filing, down from 23.42% in the prior quarter.
- Across five years, EBITDA Margin topped out at 23.42% in Q4 2025 and bottomed at 19.49% in Q2 2022.
- Median EBITDA Margin over the past 5 years was 21.64% (2024), compared with a mean of 21.7%.
- Peak annual rise in EBITDA Margin hit 242bps in 2022, while the deepest fall reached -46bps in 2022.
- Over 5 years, EBITDA Margin stood at 20.46% in 2022, then increased by 3bps to 21.02% in 2023, then rose by 10bps to 23.09% in 2024, then rose by 1bps to 23.42% in 2025, then dropped by -1bps to 23.22% in 2026.
- Business Quant data shows EBITDA Margin for CTAS at 23.22% in Q1 2026, 23.42% in Q4 2025, and 22.73% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Relx | 81.40 Bn | 81.16 Bn | - | - |
| 2 | Rentokil Initial | 79.56 Bn | 78.10 Bn | - | 7.67% |
| 3 | Cintas | 69.26 Bn | 69.08 Bn | 1.45 Bn | 23.22% |
| 4 | Copart | 33.09 Bn | 28.01 Bn | 971.24 Mn | 34.65% |
| 5 | UL Solutions | 20.56 Bn | 20.32 Bn | 381.00 Mn | 18.21% |
| 6 | Global Payments | 19.88 Bn | 14.69 Bn | 1.70 Bn | -0.53% |
| 7 | Rb Global | 19.08 Bn | 18.89 Bn | 869.50 Mn | 17.62% |
| 8 | Aramark | 13.57 Bn | 13.16 Bn | 426.35 Mn | 4.48% |
| 9 | Amentum Holdings | 5.65 Bn | 5.74 Bn | 345.00 Mn | 4.34% |
| 10 | Dolby Laboratories | 5.15 Bn | 4.56 Bn | 350.90 Mn | 28.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 23.22% |
| Nov 30, 2025 | 23.42% |
| Aug 31, 2025 | 22.73% |
| May 31, 2025 | 22.40% |
| Feb 28, 2025 | 23.37% |
| Nov 30, 2024 | 23.09% |
| Aug 31, 2024 | 22.43% |
| May 31, 2024 | 22.16% |
| Feb 29, 2024 | 21.64% |
| Nov 30, 2023 | 21.02% |
| Aug 31, 2023 | 21.37% |
| May 31, 2023 | 20.61% |
| Feb 28, 2023 | 20.40% |
| Nov 30, 2022 | 20.46% |
| Aug 31, 2022 | 20.32% |
| May 31, 2022 | 19.49% |
| Feb 28, 2022 | 20.79% |
| Nov 30, 2021 | 19.83% |
| Aug 31, 2021 | 20.78% |
| May 31, 2021 | 19.42% |
| Feb 28, 2021 | 18.37% |
| Nov 30, 2020 | 20.08% |
| Aug 31, 2020 | 20.02% |
| May 31, 2020 | 12.81% |
| Feb 29, 2020 | 17.38% |
| Nov 30, 2019 | 18.14% |
| Aug 31, 2019 | 16.90% |
| May 31, 2019 | 17.53% |
| Feb 28, 2019 | 16.54% |
| Nov 30, 2018 | 16.04% |
| Aug 31, 2018 | 15.62% |
| May 31, 2018 | 15.90% |
| Feb 28, 2018 | 12.59% |
| Nov 30, 2017 | 14.64% |
| Aug 31, 2017 | 15.46% |
| May 31, 2017 | 11.59% |
| Feb 28, 2017 | 15.29% |
| Nov 30, 2016 | 15.77% |
| Aug 31, 2016 | 16.10% |
| May 31, 2016 | 15.29% |